Prakiraan volume dodolan Advanced Biomed Inc (ADVB)
The assessment of prospective sales for Advanced Biomed Inc (ADVB) on GURU.Markets features a price chart to analyze the resilience of Advanced Biomed Inc (ADVB) to crises due to the non-cyclical nature of cancer screening. Success is based on test accuracy and partnerships with clinics, while growth relies on R&D innovations in tumor diagnostics. The current 0.00 metric determines this parameter level, signaling product demand and asset strength.
Advanced Biomed Corp (ADVB) - rincian metrik lan laporan keuangan
- kuotasi lan prakiraan analis:
- rincian kapitalisasi pasar:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Ekuitas Advanced Biomed Inc|ADVB - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Advanced Biomed Inc|ADVB - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Advanced Biomed Inc.|ADVB - Utang jangka dawa|Utang jangka cendhak perusahaan Advanced Biomed|Indikator likuiditas cepet advanbiomed.com
- rincian asil keuangan lan kelipatan valuasi:
ADVB - Bathi pungkasan|Proyeksi bathi mangsa ngarep Advanced Biomed Inc|ADVB - Rasio rega marang bathi|Pangali Forward P/E Advanced Biomed Inc|ADVB - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Advanced Biomed Inc.|ADVB - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Advanced Biomed|ADVB - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan advanbiomed.com|ADVB - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Advanced Biomed Inc
- rincian pendapatan lan dodolan emiten:
Analisis fundamental perusahaan:Advanced Biomed
The implementation of a proprietary microfluidic platform for early oncology detection creates revenue scaling potential for Advanced Biomed Inc (ADVB). Operational successes are translated into metrics through the daily recalculation of expected cash flows from core activities. This indicator measures the business's fundamental resilience to external shocks over a prospective horizon. It is critical for investors to assess the curve's ability to hold key support levels. The dynamics of revenue expectations for the company serve as a leading indicator for decision-making.
Pesaing Advanced Biomed Inc (ADVB)
Prakiraan volume dodolan ONC|Prakiraan volume dodolan halozyme.com (HALO)|Prakiraan volume dodolan RVMD (Revolution Medicines, Inc.)|AAPG: Prakiraan pendapatan perusahaan|CGON: Volume dodolan mangsa ngarep perusahaan|URGN: Prakiraan pendapatan perusahaan|BCAX: Prakiraan volume dodolan|personalis.com (PSNL) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan Erasca|Prakiraan pendapatan perusahaan DCTH (Delcath Systems Inc)|Prakiraan volume dodolan YMAB|Volume dodolan mangsa ngarep perusahaan Aura Corp AURA|Prakiraan volume dodolan CADL (Candel Therapeutics, Inc.)|accuray.com (ARAY) - Volume dodolan sing dikarepake perusahaan|SELLAS Life Sciences Group Inc. - Prakiraan volume dodolan|ACTU (Actuate Therapeutics Inc.) - Prakiraan pendapatan perusahaan|CTOR (Citius Oncology, Inc) - Volume dodolan mangsa ngarep perusahaan|TuHURA Biosciences - Pendapatan mangsa ngarep perusahaan|TARA (Protara Therapeutics) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan FATE|Prakiraan volume dodolan WHWK|Dodolan mangsa ngarep perusahaan tscan.com|Prakiraan pendapatan perusahaan Champions Oncology, Inc. CSBR|XBiotech Inc (XBIT) - Volume dodolan sing dikarepake perusahaan|CVM - Prakiraan pendapatan perusahaan|ostherapies.com (OSTX) - Volume dodolan mangsa ngarep perusahaan|RADX: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Artiva Biotherapeutics (ARTV)|ANL (Adlai Nortye Ltd) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan VERU (Veru Corporation)|Volume dodolan mangsa ngarep perusahaan TPST (Tempest Therapeutics)|XLO (xiliotx.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan RENB (Renovaro)|Dodolan mangsa ngarep perusahaan Mural Oncology PLC (MURA)|KAPA - Prakiraan pendapatan perusahaan|OKUR (OnKure Therapeutics Inc) - Prakiraan pendapatan perusahaan|GDTC: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Curis|APLM (Apollomics Inc.) - Prakiraan volume dodolan|Prakiraan volume dodolan Tharimmune Inc|Prakiraan volume dodolan GNPX|calidibio.com - Prakiraan pendapatan perusahaan|Sunshine Biopharma - Volume dodolan mangsa ngarep perusahaan|Xenetic Biosciences Inc. - Prakiraan pendapatan perusahaan|Salarius Pharmaceuticals, Inc. - Prakiraan volume dodolan|PPBT: Prakiraan pendapatan perusahaan|AONC: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan BeiGene Ltd|CKPT (Checkpoint Therapeutics) - Prakiraan volume dodolan|Prakiraan volume dodolan Elevation Oncology Inc.|Prakiraan pendapatan perusahaan iCAD, Inc. (ICAD)|ikenaoncology.com - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan NTBL (Notable Labs Inc.)|VIRX - Volume dodolan mangsa ngarep perusahaan|MorphoSys AG - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan nayabiosciences.com|Ascentage Pharma (AAPGV) - Prakiraan pendapatan perusahaan
